67.00 USD
↘ 4.11 (5.78%)AT CLOSE (11:59 AM EDT)
Disc Medicine, Inc. Common Stock
IRONNASDAQ • USD
66.97
↘ 0.04 (0.05%)
POST MARKET (AS OF 06:23 PM EDT)
Post Market
AS OF 06:23 PM EDT
66.97
↘ 0.04 (0.05%)
Market: CLOSED
Open?$70.51
High?$71.82
Low?$66.74
Prev. Close?$71.11
Volume?454.5K
Avg. Volume?464.1K
VWAP?$68.23
Rel. Volume?0.98x
Bid / Ask
Bid?$57.86 × 100
Ask?$77.02 × 100
Spread?$19.16
Midpoint?$67.44
Valuation & Ratios
Market Cap?2.6B
Shares Out?38.2M
Float?31.2M
Float %?82.7%
P/E Ratio?N/A
P/B Ratio?3.72
EPS?-$6.32
Dividend?0.00%
Ex-Dividend?N/A
Disc Medicine, Inc. Common Stock (IRON) is currently trading at $67.00. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place IRON at a fair price relative to peers.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Employees
155
Market Cap
2.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-02-08
Address
321 ARSENAL STREET, SUITE 101
WATERTOWN, MA 02472
Phone: (617) 674-9274
WATERTOWN, MA 02472
Phone: (617) 674-9274
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?23.76Safe
Confidence?49%Low
Short InterestVery High
Short % of Float?18.17%High
Short Interest?5.7M
Days to Cover?10.6
Free Float31.2M
Avg Daily Volume537.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?24.00Strong
Quick Ratio?24.00Strong
Cash Ratio?2.86Strong
Debt/Equity?0.04Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.72FAIR▾
Peers100
S&P47
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-9.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-35.1%WEAK▾
S&P5
ROA?-32.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-201335000
Enterprise Value?$2.5B
Fundamentals ratios updated end of day